跳至主要内容
临床试验/NCT03025997
NCT03025997已完成不适用

The Effect of Orally Applied Encapsulated Lipids in Yoghurt on Satiety and Food Intake: a Randomized Single-blind Placebo-controlled Study With Cross-over Design

Maastricht University Medical Center1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2017年1月24日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
33
试验地点
1
主要终点
ad libitum food intake

研究概览

简要总结

This study evaluates the ability of encapsulation of orally applied lipids in a yoghurt snack to modify ad libitum food intake and satiety, without GI symptoms. Every subject receives two treatments (active, and placebo) on two different days, following a randomized cross-over design.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BMI between 25-30 kg/m2
  • Voluntary participation

排除标准

  • Milk (-protein or lactose)- allergy/intolerance
  • History of serious GI complaints/surgeries
  • Pregnancy, lactation
  • Excessive alcohol consumption (>20 per week)
  • Abnormal eating behaviour
  • Intention to stop smoking
  • Reported unexplained weight loss or gain in the month prior to screening
  • Self-admitted HIV-positive state

研究组 & 干预措施

Active yoghurt

Active Comparator

Yoghurt snack containing encapsulated lipid

干预措施: Active yoghurt (Dietary Supplement)

Placebo yoghurt

Placebo Comparator

Yoghurt snack containing non-encapsulated lipid

  • empty encapsulation matrix

干预措施: Placebo yoghurt (Dietary Supplement)

结局指标

主要结局

ad libitum food intake

时间窗: 2 hours after yoghurt snack

t=0: standardized breakfast, t=90 minutes: yoghurt, t=210 minutes: ad libitum food intake

次要结局

  • Satiety feelings(Up to 3.5 hours on each of the 2 test days.)
  • occurrence and severity of GI symptoms(Up to 3.5 hours on each of the 2 test days.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验